Literature DB >> 15368309

Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions.

Véronique Pascal1, Nicolas Schleinitz, Corinne Brunet, Sophie Ravet, Elodie Bonnet, Xavier Lafarge, Mhammed Touinssi, Denis Reviron, Jean Francois Viallard, Jean Francois Moreau, Julie Déchanet-Merville, Patrick Blanco, Jean Robert Harlé, José Sampol, Eric Vivier, Françoise Dignat-George, Pascale Paul.   

Abstract

We have characterized the heterogeneity of human blood NK cell subsets defined by expression of KIR, lectin like receptors and NK cell differentiation markers within a cohort of 51 healthy Caucasian individuals. High inter-individual variability in cell surface expression of most NK cell markers is observed. Range values defining NK cell subsets in healthy donors were further used as references to characterize 14 patients with NK-type lymphoproliferative disease of granular lymphocytes (NK-LDGL). Alterations of the KIR repertoire were noted in all NK-LDGL patients. NK cell expansions were classified as oligoclonal KIR(+) or as non-detectable KIR ((nd)KIR) using anti-KIR2DL1/2DS1, anti-KIR2DL2/2DL3/2DS2, anti-KIR3DL1 and anti-KIR2DS4 monoclonal antibodies. A major reduction in the size of the CD56(bright) NK cell subset was a constant feature of NK-LDGL. Altered distribution of CD94(+), CD161(+), and CD162R(+) NK cell subsets was also observed in NK-LDGL patients. Considering the potential role of NK cells in eliminating tumors or virus-infected cells, the reference values defined in this study should be valuable to characterize both quantitative and qualitative alterations of the NK cell repertoire in pathological conditions and to monitor NK cell reconstitution following hematopoietic transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15368309     DOI: 10.1002/eji.200425146

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

Review 1.  Natural killer cells in human autoimmune diseases.

Authors:  Nicolas Schleinitz; Frédéric Vély; Jean-Robert Harlé; Eric Vivier
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

2.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

3.  Distribution of several activating and inhibitory receptors on CD3-CD16+ NK cells and their correlation with NK cell function in healthy individuals.

Authors:  Gordana Konjević; Katarina Mirjacić Martinović; Ana Vuletić; Vladimir Jurisić; Ivan Spuzić
Journal:  J Membr Biol       Date:  2009-08-27       Impact factor: 1.843

4.  Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells.

Authors:  Hyun Don Yun; Martin Felices; Daniel A Vallera; Peter Hinderlie; Sarah Cooley; Michel Arock; Jason Gotlib; Celalettin Ustun; Jeffrey S Miller
Journal:  Blood Adv       Date:  2018-07-10

5.  Changes in natural killer cell subsets in pediatric liver transplant recipients.

Authors:  Betty Pham; Karine Piard-Ruster; Richard Silva; Amy Gallo; Carlos O Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Pediatr Transplant       Date:  2012-03

6.  Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.

Authors:  Gordana Konjević; Katarina Mirjacić Martinović; Ana Vuletić; Viktor Jović; Vladimir Jurisić; Nada Babović; Ivan Spuzić
Journal:  Clin Exp Metastasis       Date:  2007-02-13       Impact factor: 4.510

7.  Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.

Authors:  Yi Li; Jia Wei; Xia Mao; Qingping Gao; Longlong Liu; Ping Cheng; Limei Liu; Xinhua Zhang; Ke Zhang; Jin Wang; Li Zhu; Jianfeng Zhou; Yicheng Zhang; Li Meng; Hanying Sun; Dengju Li; Mei Huang; Wei Huang; Jinniu Deng; Donghua Zhang
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

8.  Pattern of DAP12 expression in leukocytes from both healthy and systemic lupus erythematosus patients.

Authors:  Nicolas Schleinitz; Laurent Chiche; Sophie Guia; Gaëlle Bouvier; Julie Vernier; Alexis Morice; Elisabeth Houssaint; Jean Robert Harlé; Gilles Kaplanski; Félix A Montero-Julian; Frédéric Vély
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

9.  Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells.

Authors:  Gal Markel; Rachel Seidman; Michal J Besser; Naama Zabari; Rona Ortenberg; Ronnie Shapira; Avraham J Treves; Ron Loewenthal; Arie Orenstein; Arnon Nagler; Jacob Schachter
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

10.  Modulation of the inhibitory receptor leukocyte Ig-like receptor 1 on human natural killer cells.

Authors:  Nicholas L Li; Chelsea L Davidson; Atul Humar; Deborah N Burshtyn
Journal:  Front Immunol       Date:  2011-09-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.